Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?

Overview ForecastFinancials Chart Transcripts

Capricor Therapeutics Ownership Summary

Capricor Therapeutics is owned by 26.23% institutional investors, 16.80% insiders, and 56.97% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.24% of CAPR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.55% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Capricor Therapeutics	26.23%	16.80%	56.97%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	2.85M	6.24%	$82.28M
Vanguard group	2.56M	5.60%	$73.94M
Blackrock	1.63M	5.19%	$7.77M
Geode capital management	1.02M	2.23%	$29.37M
State street	801.34K	1.75%	$5.78M
Soleus capital management	646.39K	1.41%	$18.65M
Morgan stanley	585.84K	1.28%	$16.91M
J. goldman & co lp	481.98K	1.05%	$3.48M
Dg capital management	470.33K	1.03%	$3.39M
Goldman sachs group	447.98K	0.98%	$12.93M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Moody aldrich partners	226.03K	1.24%	$6.87M
Dg capital management	470.33K	1.18%	$3.39M
Soleus capital management	646.39K	0.69%	$18.65M
Black diamond financial	79.08K	0.26%	$2.40M
Seven grand managers	100.00K	0.20%	$3.04M
Ikarian capital	264.64K	0.19%	$1.91M
Stoneridge investment partners	8.40K	0.18%	$255.00K
Ellerson group inc /adv	7.89K	0.16%	$239.86K
Act capital management	5.00K	0.12%	$152.00K
Hbk sorce advisory	203.71K	0.12%	$5.04M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.63M	0.00%	1.25M
Soleus capital management	646.39K	0.69%	646.39K
J. goldman & co lp	481.98K	0.09%	481.98K
Dg capital management	470.33K	1.18%	470.33K
Vanguard group	2.56M	0.00%	355.16K

Top Sellers

Holder	Shares	% Assets	Change
Altium capital management lp	-	-	-714.00K
State street	801.34K	0.00%	-665.34K
Pier capital	-	-	-496.55K
Octagon capital advisors lp	-	-	-450.00K
Superstring capital management lp	-	-	-241.19K

New Positions

Holder	Shares	% Assets	Change	Value
Soleus capital management	646.39K	0.69%	646.39K	$18.65M
J. goldman & co lp	481.98K	0.09%	481.98K	$3.48M
Dg capital management	470.33K	1.18%	470.33K	$3.39M
Vanguard fiduciary trust	320.10K	0.00%	320.10K	$9.73M
Ikarian capital	264.64K	0.19%	264.64K	$1.91M

Sold Out

Holder	Change
Aquatic capital management	-1.00
True wealth design	-5.00
Northwestern mutual wealth management	-19.00
Eversource wealth advisors	-35.00
C m bidwell & associates	-43.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	73	-47.86%	11,993,578	-17.25%	26	2.61%	45	-30.77%	24	-33.33%
Sep 30, 2025	136	-	14,466,244	5.28%	31	3.50%	62	-6.06%	36	-7.69%
Jun 30, 2025	132	-7.04%	13,682,657	-27.15%	29	1.77%	63	-24.10%	40	37.93%
Mar 31, 2025	10	-92.48%	930,147	-94.63%	2	0.08%	7	-92.39%	2	-86.67%
Dec 31, 2024	40	-57.45%	6,498,502	-22.35%	19	3.07%	32	-42.86%	3	-72.73%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.46M	2.55%	1.22K
State Street® SPDR® S&P® Biotech ETF	1.29M	2.23%	-12.93K
Vanguard US Total Market Shares ETF	872.18K	1.91%	-
iShares Russell 2000 ETF	1.02M	1.77%	8.60K
SPDR® S&P Biotech ETF	584.18K	1.28%	1.30K
Vanguard Institutional Extnd Mkt Idx Tr	514.36K	0.89%	12.08K
Fidelity Small Cap Index	376.88K	0.65%	3.97K
iShares Russell 2000 Growth ETF	356.50K	0.62%	918.00
Fidelity Select Biotechnology	314.70K	0.54%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	227.13K	0.50%	1.15K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 01, 2026	Krasney Karen	EVP, GENERAL COUNSEL	Sell	$792.55K
May 01, 2026	Bergmann Anthony	CHIEF FINANCIAL OFFICER	Sell	$792.54K
Apr 02, 2026	Sabar Karimah Es	-	Sell	$240.93K
Mar 31, 2026	Krasney Karen	EVP, GENERAL COUNSEL	Sell	$752.93K
Mar 31, 2026	Sabar Karimah Es	-	Sell	$1.85M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	2
2026 Q1	-	3
2025 Q4	-	-
2025 Q1	-	-
2024 Q4	-	-

CAPR Ownership FAQ

Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 26.23%, followed by 16.80% insiders and 56.97% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 382.13%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock funding, inc. /de (2.85M shares, 6.24%), Vanguard group (2.56M shares, 5.60%), and Blackrock (1.63M shares, 5.19%). Together, they hold 17.03% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Moody aldrich partners is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.24% of its assets in 226.03K Capricor Therapeutics shares, valued at 6.87M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Capricor Therapeutics shares, with 2.55% of its total shares outstanding invested in 1.46M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools